Void Research COA Lookup, Purity, and Batch-Testing Detailed FAQ: BOOST30 Discount Code — Up to 30% Off
For researchers comparing peptide suppliers, a Certificate of Analysis should be treated as a batch-specific analytical record rather than a decorative “quality tested” badge. A useful COA helps answer several different questions: Is the material chemically consistent with the stated compound? How pure is the tested sample? How much peptide was measured? Which contaminants or microbiological markers were examined? Which laboratory performed the testing? Most importantly, does the certificate actually correspond to the lot in front of the researcher?
Void Research currently publishes a public COA system built around those questions. Its main certificates page describes an eight-part testing framework covering HPLC purity, net peptide content, LC-MS identity, HPLC conformity, heavy metals, sterility screening, bacterial endotoxin testing, and a fentanyl screen. The company states that results are associated with individual lots rather than presented only as general supplier-wide claims.
Affiliate disclosure: This post contains an affiliate link; the publisher may earn a commission from qualifying purchases.
Void Research materials are marketed strictly for controlled in-vitro or laboratory research by qualified researchers. They are not intended for human or veterinary use, consumption, administration, diagnosis, treatment, cure, prevention, clinical application, food, supplements, cosmetics, or personal experimentation. That distinction should remain separate from any discussion of analytical documentation.
Researchers who want to review the current Void Research catalog and its documentation can use Void Research with BOOST30. The campaign code is BOOST30 for up to 30% off.
The purpose of this guide is not simply to repeat a purity percentage. It is to explain what the different COA fields mean, how researchers can match a vial or product lot to the correct certificate, where common interpretation mistakes occur, and why HPLC purity, molecular identity, measured content, contamination screening, and batch traceability answer different analytical questions.
What is a Void Research COA?
A Certificate of Analysis, usually shortened to COA, is a document associated with analytical testing of a particular material or production lot.
In practical procurement terms, a COA should help connect three things:
the product identity,
the specific lot or batch,
and the analytical results reported for that lot.
That connection is important because a supplier can test one batch today and produce another batch later. A purity result from the first lot does not automatically describe the second lot.
Void Research’s current public documentation emphasizes batch-level certificates. On supported product pages, the company states that the vial’s lot identifier is printed on the label and that researchers should use that identifier to locate the corresponding certificate. Some product pages display both a latest certificate and superseded certificates, making the lot number more important than simply opening the first COA visible on the site.
This batch-specific approach is why a researcher should ask:
“Does this certificate belong to my lot?”
before asking:
“What purity percentage does it show?”
A detailed earlier explanation of the same principle can be found in the Void Research guide to matching a vial lot with the correct COA.
Where can researchers look up Void Research COAs?
Void Research maintains a public Certificates of Analysis section on its website, and individual product pages may also display lot-specific certificate information.
The central COA page currently describes the company’s testing program as eight separate assays performed on lots before shipping. It presents the following categories:
HPLC purity
Net peptide content
LC-MS identity
HPLC conformity
Heavy metals
Sterility screening
Endotoxin testing
Fentanyl screening
The company states that the measured results are reported on the applicable lot certificate rather than replaced with a simple marketing summary.
For a researcher, however, the most useful workflow is not merely “open the COA page.”
It is:
identify the product,
identify the lot,
find the certificate for that lot,
confirm the testing laboratory and date,
review each individual assay,
and distinguish what was measured from what was not measured.
That last distinction is especially important. A single purity figure does not contain the same information as a full identity, content, elemental, microbiological, and contaminant-testing package.
How should a researcher match a vial to the correct COA?
The safest reading process begins with the physical or recorded lot identifier rather than the headline purity number.
A practical sequence is:
Step 1: Record the product name exactly.
Blends, related analogues, different strengths, and similarly named materials can have separate documentation. Never assume that a certificate for a related item applies to another product.
Step 2: Locate the lot or batch number on the label.
The lot number is the primary traceability bridge between the received material and the analytical record.
Step 3: Open the supplier’s COA archive or product page.
Locate the matching batch rather than relying on the newest certificate automatically.
Step 4: Compare secondary identifiers.
Depending on the certificate, these may include certificate number, accession number, cap description, strength, testing date, or laboratory name.
Step 5: Confirm whether the certificate is current or superseded.
A superseded COA can still be relevant when it corresponds to an older lot. “Superseded” does not necessarily mean “invalid”; it may simply mean that a newer production lot has since been tested.
Step 6: Read the assay rows themselves.
Do not stop after seeing a badge such as “99%+ purity.”
Void Research product pages illustrate why this matters. For example, archived product documentation can show newer and older lots separately, with distinct assay counts, dates, measured content, certificate identifiers, and laboratories.
Why is the lot number more important than the supplier-wide purity claim?
Suppose a company states that its products are “99%+ purity.”
That statement may describe a general quality target, but it is not a substitute for the result from the exact batch being evaluated.
Laboratory materials are produced in lots because manufacturing, purification, handling, storage, and testing occur at specific points in time. Different lots can have different analytical measurements even when they carry the same product name.
Therefore, the stronger question is not:
“Does Void Research say its peptides are 99% pure?”
It is:
“What does the COA for this particular Void Research lot report?”
This is one reason the current site’s lot-level documentation is more useful than relying solely on the front-page claim. Void Research currently markets its catalog around 99%+ purity while separately providing certificates and lot-level documentation.
What does HPLC purity mean?
HPLC stands for high-performance liquid chromatography.
In simplified terms, chromatography separates components of a sample as they interact differently with a chromatographic system. The resulting chromatogram can show a principal peak associated with the target material together with additional peaks representing other detectable components under the test conditions.
A reported HPLC purity percentage generally expresses the relative chromatographic purity of the tested sample according to the laboratory’s method.
This can be useful, but researchers should understand exactly what it does and does not establish.
A high HPLC purity result can support the conclusion that the sample contains a dominant chromatographic component under the tested conditions.
It does not, by itself, prove every other attribute of the material.
It does not automatically establish:
the molecular identity,
the exact amount of peptide in the vial,
the absence of all elemental contaminants,
the absence of endotoxin,
the absence of microbial contamination,
or the absence of unrelated adulterants that were not part of the method.
That is why purity and identity should not be treated as synonyms.
For a deeper comparison, see the previously published guide to Void Research HPLC purity versus LC-MS identity and net peptide content.
Is 99% HPLC purity the same as 99% peptide content?
No.
This is one of the most important distinctions in peptide documentation.
HPLC purity and net peptide content answer different questions.
A sample may produce a chromatogram in which the dominant component represents a very high percentage of the chromatographically detected material, while the absolute quantity of the target peptide in the container is a separate measurement.
Imagine, purely as an analytical example, that a test reports chromatographic purity above 99%.
That does not necessarily mean that a vial labeled with a particular milligram quantity contains exactly that number of milligrams of target peptide.
The purity result concerns the composition of the measured chromatographic signal.
Net content concerns how much target material is present.
Void Research’s current testing framework lists these as separate assay categories for that reason: “Purity HPLC” and “Net Peptide Content” appear independently.
When evaluating documentation, researchers should therefore avoid phrases such as:
“99.8% pure means the vial contains 99.8% of the labeled milligrams.”
That conclusion cannot be drawn from chromatographic purity alone.
What is net peptide content?
Net peptide content refers to the measured quantity of peptide associated with the tested vial or sample.
This measurement helps answer a question different from purity:
“How much of the target peptide is actually present relative to the labeled amount?”
For procurement, experimental planning, and quality review, that distinction can be important.
A certificate may show:
the labeled quantity,
the measured quantity,
and sometimes component-specific measured quantities for a blend.
Void Research’s current product documentation demonstrates this format on certain products. The latest KLOW certificate, for example, separately displays the labeled total and measured amounts for its individual components rather than treating chromatographic purity as a substitute for content.
The correct interpretation is therefore:
purity describes chromatographic composition,
while content describes quantity.
Neither should automatically replace the other.
What is LC-MS identity testing?
LC-MS combines liquid chromatography with mass spectrometry.
In peptide analysis, mass-spectrometric information can be used to support molecular identification by examining mass-related characteristics of the tested compound.
This addresses an analytical question that HPLC purity alone cannot fully answer.
A material can potentially produce a strong chromatographic peak without that peak, by itself, proving that the molecule is the expected peptide.
That is why a complete analytical review asks two separate questions:
“How clean is the chromatographic profile?”
and
“Does the analytical evidence support the claimed molecular identity?”
Void Research’s present eight-assay framework lists LC-MS identity separately from HPLC purity and HPLC conformity.
Researchers comparing certificates should therefore look for a clearly stated identity method rather than assuming that a purity percentage automatically confirms molecular identity.
What is HPLC conformity?
Void Research separately lists “HPLC conformity,” describing it as comparison of a lot chromatogram with the reference trace for the compound.
Conceptually, this is different from simply reporting a percentage.
A purity percentage reduces chromatographic information to a numerical result.
A conformity assessment asks whether the chromatographic behavior of the tested lot aligns with the expected reference pattern under the defined method.
This can add context, but researchers should still read the certificate carefully.
Important questions include:
What reference was used?
Was a certified reference standard involved?
Does the certificate provide a chromatogram?
What method conditions were used?
Is the conformity result numerical, qualitative, or both?
A certificate becomes more informative when it exposes enough analytical detail for the reader to understand how the conclusion was reached.
What are heavy-metal tests looking for?
Void Research’s published framework states that heavy-metal screening is performed by ICP-MS for lead, arsenic, cadmium, and mercury.
ICP-MS stands for inductively coupled plasma mass spectrometry.
Elemental testing is analytically distinct from peptide purity testing.
An HPLC chromatogram is not designed to replace a dedicated elemental analysis.
Therefore, a researcher who cares about elemental contamination should look for the specific metals tested, the method, the reported values or limits, and any specification applied.
A generic statement such as “high purity” should not be interpreted as proof that lead, arsenic, cadmium, or mercury were examined.
This is another reason a multi-assay COA can provide more information than a single headline number.
What does endotoxin testing mean?
Endotoxins are associated with the outer membrane of Gram-negative bacteria. Analytical testing for bacterial endotoxins is a separate quality-control question from peptide identity or chromatographic purity.
The United States Pharmacopeia recognizes bacterial endotoxin testing in Chapter <85>, and FDA’s March 2026 guidance discusses USP <85> alongside methods and acceptance considerations for regulated products.
Void Research currently lists “Endotoxin USP <85>” in its eight-assay framework and says the measured value is reported rather than reduced only to a generic pass statement.
For research readers, the useful details are:
the method or standard cited,
the numerical result when provided,
the reporting unit,
the specification or threshold shown on the certificate,
and the particular lot to which the test applies.
Researchers should also avoid confusing endotoxin testing with sterility testing.
A sample can be assessed for bacterial endotoxin through one analytical framework while microbiological contamination or sterility is evaluated through another.
They are not interchangeable concepts.
Is endotoxin testing the same as sterility testing?
No.
Sterility and endotoxin are related to contamination control, but they describe different analytical concerns.
Sterility testing is concerned with viable microorganisms or evidence of microbial contamination according to the method being used.
Endotoxin testing focuses on bacterial endotoxins, which can remain analytically relevant even when viable Gram-negative bacteria are no longer present.
USP separately identifies Chapter <71> for sterility tests and Chapter <85> for bacterial endotoxins.
This means a certificate stating that a sample passed an endotoxin test should not automatically be interpreted as proof of sterility.
Likewise, a sterility-related result does not automatically establish an endotoxin value.
Void Research currently lists these as two separate categories within its testing framework: a sterility screen and an endotoxin result.
What does Void Research mean by a sterility screen?
The current Void Research COA page describes its sterility category as a PCR screen and states that the certificate reports whether growth was found.
Researchers should read the exact certificate method instead of generalizing that wording into a broader pharmaceutical or compendial claim.
This is particularly important because laboratory terms such as “sterility,” “PCR,” “growth,” and compendial sterility testing can refer to different methodologies, validation requirements, and reporting conventions.
A procurement reader should therefore ask:
Which method was actually used on this lot?
Which laboratory performed it?
What exactly does the certificate say?
Was the result quantitative or qualitative?
What specification was applied?
A detailed COA is strongest when these questions can be answered directly from the record.
Why is there a fentanyl screen?
Void Research’s public testing framework includes screening for fentanyl and its analogs as one of its eight categories.
This is not a measure of peptide purity, molecular identity, or content.
It is a targeted contaminant screen.
Its presence illustrates a broader COA principle: each analytical test answers a defined question.
HPLC asks one set of questions.
LC-MS identity testing asks another.
ICP-MS elemental testing asks another.
Endotoxin testing asks another.
A targeted fentanyl screen asks yet another.
Researchers should therefore evaluate certificates assay by assay rather than compressing the entire document into a single “passed testing” judgment.
Does every historical Void Research certificate show eight assays?
Researchers should check the actual lot certificate rather than assume that every certificate visible in the archive has the same structure.
Void Research’s current central COA page describes an eight-test framework for lots before shipping. However, some publicly visible older or superseded product certificates show fewer listed assays.
For example, current product-page archives for KLOW and GLOW include historical certificates with smaller assay counts than the eight-part program promoted on the main COA page.
The reasonable interpretation is not that every historical certificate is identical to the current testing program.
Instead, researchers should distinguish between:
the supplier’s current testing framework,
the exact certificate attached to a particular lot,
and historical or superseded documentation.
This is why the lot-specific record should always control the interpretation.
If a researcher receives an older lot, the relevant question is what that specific certificate reports—not what a newer batch reports.
What information should a strong COA contain?
There is no value in treating every document labeled “COA” as equally informative.
A practical research-oriented certificate should allow the reader to identify, at minimum, several of the following:
product or compound name,
lot or batch number,
certificate or accession number,
testing date,
testing laboratory,
sample strength or labeled quantity,
measured content,
purity result,
identity result,
method name,
contaminant-screening results where applicable,
microbiological or endotoxin results where applicable,
and specifications or acceptance criteria when the laboratory provides them.
The more traceable the document, the easier it is for procurement personnel or research teams to determine whether the analytical record belongs to the material under review.
A more detailed explanation aimed at procurement readers is available in the earlier Void Research COA data guide for researchers and purchasing teams.
How can researchers evaluate the testing laboratory?
A COA should not be evaluated only by the supplier name.
The laboratory performing the analysis also matters.
Useful questions include:
Is the laboratory clearly named?
Does the certificate contain an accession or report number?
Can the report be independently verified?
Does the laboratory state the analytical method?
Does the certificate show the testing date?
Are reference standards or specifications identified?
Does the report contain sufficient detail to distinguish one lot from another?
Some Void Research product pages presently display the testing laboratory and certificate identifiers for specific lots, and certain certificates include access-code or verification information.
That type of detail is useful because it allows a researcher to evaluate the analytical record as a document rather than simply trusting an isolated percentage copied onto a product page.
Should researchers rely only on the newest COA?
Not automatically.
The newest certificate is relevant only if it corresponds to the lot being evaluated.
Suppose a product page displays a new certificate tested in August and a superseded certificate tested in May.
If the vial label corresponds to the May lot, then the May certificate is the relevant record.
The August document might describe the newest inventory, but it would not retroactively become the analytical record for the older lot.
This is one of the most common COA interpretation errors.
“Newest” and “matching” are not synonymous.
The matching lot is the important one.
What if the lot number cannot be found?
If a researcher cannot locate a certificate matching the lot identifier, the appropriate response is to treat the documentation as incomplete until the batch can be reconciled.
Do not substitute a certificate from another lot simply because it is the same product.
Do not average results across several lots.
Do not assume that the newest batch is representative of an unverified older batch.
Instead, preserve the lot information and contact the supplier for the corresponding documentation if appropriate.
Batch traceability is valuable precisely because it avoids those assumptions.
Does a COA prove that a research material is suitable for every experiment?
No.
A COA documents the tests that were performed and the results produced under those test methods.
Suitability for a particular research project depends on the requirements of that project.
A laboratory might require:
a specific purity threshold,
an identity confirmation method,
a particular content tolerance,
heavy-metal limits,
endotoxin limits,
sterility-related documentation,
additional impurity characterization,
or another analytical requirement not contained in a standard supplier certificate.
Therefore, a COA should be read as evidence—not as a universal guarantee of fitness for every conceivable protocol.
The research team remains responsible for determining which specifications are appropriate for its work.
Can a 99%+ purity claim replace a COA?
No.
A marketing purity claim can summarize a supplier’s target or typical specification, but the COA provides the lot-specific analytical context.
Void Research currently promotes 99%+ purity while also directing researchers toward batch documentation and COAs.
For serious documentation review, the second part matters more.
Researchers should want to know:
Which lot?
Which laboratory?
Which method?
Which result?
Which date?
Which specification?
Those questions transform “99%+ purity” from a marketing phrase into something that can be evaluated analytically.
Why should purity, identity, and quantity be reviewed together?
These three fields address three separate dimensions of quality documentation.
Purity: How much of the chromatographically observed material corresponds to the main component relative to detectable impurities under the method?
Identity: Does the analytical evidence support that the compound is the molecule stated on the label?
Quantity: How much target material is actually measured?
A researcher can obtain a much more complete picture when all three are available.
A high purity number without identity data leaves an obvious question.
Identity confirmation without a quantity measurement leaves another.
A quantity measurement without purity information leaves yet another.
This is why the earlier complete Void Research eight-assay testing guide is useful as companion reading: it treats the different testing categories as separate evidence rather than collapsing them into one number.
How should a research team record COA information internally?
A concise internal record can significantly improve traceability.
For each received lot, a research team might record:
Product: exact catalog name
Lot: exact lot number from label
COA number: if provided
Testing laboratory: named laboratory
Test date: date shown on certificate
HPLC purity: reported result
Identity: reported method and result
Net content: measured quantity
Heavy metals: results or limits if present
Sterility-related result: method and outcome if present
Endotoxin: reported value and units
Targeted screens: result if present
Certificate location: archive or internally retained copy
Reviewed by: responsible team member
Review date: date of internal review
This does not replace the original certificate.
It creates an internal traceability layer so that researchers can later determine which analytical record accompanied which material.
Can researchers compare COAs from different suppliers directly?
They can compare them, but only if they pay attention to methodology.
Two certificates can both state “99% purity” while differing substantially in:
analytical method,
reference material,
sample preparation,
instrumentation,
reporting convention,
detection limits,
calculation method,
laboratory accreditation,
and certificate detail.
Likewise, one supplier may report only HPLC purity, while another may provide purity, LC-MS identity, content, heavy metals, endotoxin, and other screens.
A useful comparison therefore asks:
“Which questions does each certificate answer?”
rather than merely:
“Which percentage is higher?”
A 99.7% result and a 99.5% result are not automatically meaningfully different unless the methods and uncertainties are sufficiently comparable.
What is the best way to read a Void Research COA?
A good sequence is:
First, confirm the lot.
Second, confirm the product and strength.
Third, identify the testing laboratory and date.
Fourth, review purity.
Fifth, review identity.
Sixth, review measured content.
Seventh, examine any conformity, heavy-metal, microbiological, endotoxin, or targeted contaminant tests.
Eighth, note what is missing.
Ninth, compare the results with the requirements of the intended in-vitro laboratory project.
Tenth, retain the certificate with the batch record.
This order prevents the purity percentage from dominating the entire evaluation.
Mid-article BOOST30 reminder
Documentation should come first. Once a qualified researcher has reviewed the applicable product page, matched the relevant lot, and determined that the available analytical information fits the laboratory’s requirements, BOOST30 can be used as the campaign code for up to 30% off.
The promotional offer should remain secondary to product identity, batch traceability, analytical documentation, shipping eligibility, and lawful research-use requirements.
Does Void Research ship internationally?
Void Research’s shipping policy currently states that it ships internationally where permitted by law. International customers are responsible for destination-country import rules, customs requirements, duties, taxes, VAT/GST where applicable, and importer-of-record obligations. The policy also warns that customs clearance is not guaranteed and that packages may be delayed, detained, returned, seized, or destroyed by customs authorities.
Shipping availability should never be interpreted as proof that a material can legally be imported, possessed, or used in a particular jurisdiction.
Researchers should determine the requirements that apply to their institution and destination before ordering.
Does shipping documentation affect COA interpretation?
Indirectly, yes.
A COA describes analytical results.
Shipping and handling records describe chain-of-custody and logistics.
These are separate documentation layers.
A research organization may reasonably retain both because a complete batch history can include:
supplier,
order record,
lot number,
COA,
shipping record,
date received,
condition on receipt,
storage location,
and internal disposition.
The analytical certificate tells the laboratory what was reported about the tested lot.
The logistics record tells the laboratory how the material moved from supplier to recipient.
Neither should be confused with the other.
Frequently Asked Questions
Where do I find a Void Research COA?
Void Research currently maintains a central Certificates of Analysis section and also displays batch documentation on supported product pages. Start with the product and lot identifier, then locate the matching certificate.
Does Void Research publish COAs by batch?
Its current documentation is organized around lot-specific testing, and product pages can show separate latest and superseded certificates associated with different lots.
What tests does Void Research currently say it performs?
The current central COA page lists HPLC purity, net peptide content, LC-MS identity, HPLC conformity, heavy metals by ICP-MS, a sterility screen, endotoxin testing referencing USP <85>, and a fentanyl screen.
Is HPLC purity the same as peptide identity?
No. HPLC purity and molecular identity are different analytical questions. Void Research’s current framework lists HPLC purity and LC-MS identity separately.
Is purity the same as net peptide content?
No. Purity refers to chromatographic composition under the testing method, while content addresses how much target material is measured.
Does 99% purity mean the vial contains exactly 99% of the labeled milligrams?
No. That conclusion cannot be made from an HPLC purity percentage alone. Net peptide content must be evaluated separately.
Is LC-MS useful for identity confirmation?
Yes. Mass-spectrometric analysis can support molecular identity evaluation and is conceptually separate from reporting chromatographic purity.
What is HPLC conformity?
Void Research describes it as comparison of the lot chromatogram with a reference trace for the compound. It is separate from the headline purity percentage.
Does a heavy-metals result come from HPLC?
Not in the current Void Research framework. Heavy metals are listed separately using ICP-MS for lead, arsenic, cadmium, and mercury.
Is endotoxin testing the same as sterility testing?
No. USP identifies bacterial endotoxin testing separately from sterility testing, and Void Research also presents them as separate assay categories.
What is USP <85>?
USP <85> is the United States Pharmacopeia chapter addressing bacterial endotoxin testing. FDA’s 2026 guidance discusses its role and associated test principles.
Should I use the newest COA regardless of lot?
No. Use the certificate associated with the actual lot being evaluated.
What does “superseded certificate” mean?
On a product page, it can indicate an older certificate that has been replaced by a newer lot’s documentation. The older certificate may still be the correct record for an older matching batch.
What if my lot number is not in the public archive?
Do not substitute another batch. Treat the documentation as unresolved and seek the matching certificate.
Does a COA guarantee suitability for my experiment?
No. It reports analytical results for the tested sample and methods. The research team must determine whether those specifications meet the needs of its particular laboratory project.
Does a high purity number prove there are no contaminants?
No. A purity assay only provides information within the scope of that method. Separate heavy-metal, microbial, endotoxin, or targeted contaminant tests answer additional questions.
Should researchers keep their own copy of the COA?
Yes, retaining the certificate with the internal batch record can improve traceability, especially when supplier archives later add new lots or label older certificates as superseded.
Are all Void Research historical COAs identical?
No assumption should be made that historical certificates contain exactly the same assay panel. The company’s current central COA page describes eight tests, while some archived product certificates visibly list fewer assays. Review the specific lot record.
Are Void Research products intended for human use?
No. The supplier states that its materials are strictly for qualified in-vitro laboratory research and are not intended for human or veterinary use, consumption, clinical application, diagnosis, treatment, cure, or prevention of disease.
Does international shipping mean a product is legal in my country?
No. Void Research’s policy states that international shipping is offered where permitted by law, while the customer remains responsible for import legality, customs requirements, duties, taxes, and destination-country rules.
Final takeaway: read the certificate as a set of separate analytical answers
The most important lesson in peptide COA interpretation is that no single number tells the entire story.
HPLC purity answers one question.
LC-MS identity answers another.
Net peptide content addresses quantity.
HPLC conformity adds chromatographic comparison context.
ICP-MS addresses selected elemental contaminants.
Sterility-related testing addresses a microbiological question.
Endotoxin testing addresses bacterial endotoxin.
A targeted fentanyl screen addresses a specific contaminant category.
The lot number connects those results to the material being evaluated.
For qualified researchers, that is the right way to use a COA: not as a promotional badge, but as a batch-specific analytical document whose individual fields should be examined in the context of the laboratory’s own requirements.
Void Research’s current public documentation provides a useful structure for that review because its COA page separates the testing program into distinct assay categories and its product pages can associate certificates with individual lots. Researchers should still read the exact certificate for their batch, identify the laboratory and date, understand what each method demonstrates, and note any information that is absent rather than extending one test result beyond its actual scope.
For additional background, the earlier Void Research COA explainer on Substack provides another reader-oriented overview of certificate interpretation.
Review Void Research documentation and use BOOST30 for up to 30% off
Qualified researchers who have reviewed the relevant COA, confirmed the applicable lot, checked their laboratory requirements, and verified that ordering is lawful in their jurisdiction can visit Void Research through the BOOST30 affiliate link and use BOOST30 for up to 30% off.
All Void Research materials discussed here are strictly for controlled in-vitro laboratory research by qualified researchers. They are not for human or veterinary use, consumption, administration, diagnosis, treatment, cure, prevention, clinical application, food, supplements, cosmetics, or personal experimentation.
Comments
Post a Comment